Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone

To assess the rate and predictors of clinically meaningful improvements (CMI) in patients with lower urinary tract symptoms (LUTS) treated with either silodosin (SIL) alone or with a combination of SIL+ serenoa repens (Ser) hexanic lipidosterolic extract for ≥12 months. Data from 186 patients were c...

Descripción completa

Detalles Bibliográficos
Autores principales: Boeri, Luca, Capogrosso, Paolo, Ventimiglia, Eugenio, Cazzaniga, Walter, Pederzoli, Filippo, Moretti, Donatella, Dehò, Federico, Montanari, Emanuele, Montorsi, Francesco, Salonia, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680270/
https://www.ncbi.nlm.nih.gov/pubmed/29123161
http://dx.doi.org/10.1038/s41598-017-15435-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680270/
https://www.ncbi.nlm.nih.gov/pubmed/29123161
http://dx.doi.org/10.1038/s41598-017-15435-0

Ejemplares similares